FemTech

As the FemTech industry experiences significant growth in addressing the needs of women’s health, innovations are rapidly emerging to tackle the gender health gap through advanced technologies and interdisciplinary approaches.

This women-centric focus highlights previously unmet needs and supports the drive for tailored healthcare solutions. However, addressing specific conditions such as menstrual health, reproductive technology, and female oncology presents its challenges, making it imperative to develop culturally sensitive, reliable methods for diverse subpopulations of women, ensuring accessibility and efficacy of emerging technologies.

HGF’s accomplished FemTech team are experts in patent drafting, prosecution, appeals, FTO and infringement opinions, and litigation for large corporate firms, SMEs, universities, and overseas associates. Often working with experts in developmental biology, microbiome technologies, and big data technology companies, our attorneys, with backgrounds in Life Sciences, Chemistry, Electronics, Engineering, and Trade Marks, blend specialist knowledge with critical insights into rapidly evolving FemTech solutions.

We are dedicated to empowering women through innovation, ensuring that intellectual property protection generates new revenue streams, creating substantial business value, and attracting investors.

Latest updates

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article

HGF Sets the Gold Standard – Recognised for 7th Year in a Row by Financial Times

We are extremely honoured to announce that HGF has once again been ranked ‘Gold’ across all six bands in the Financial Times Special Report – Europe’s Leading Patent Law Firms …

Read article

UPC delivers first judgment on Validity and Infringement of a Second Medical Use Claim

Sanofi Biotechnology SAS & Anor v Amgen, Inc., & Ors– Thomas, Thom, Kupecz and Dorland-Galliot – [UPC_CFI_505/2024] The Dusseldorf Local Division (LD) has delivered the UPC’s first Judgment on second …

Read article

Managing IP firm rankings – Trade Marks 2025

HGF has once again been highly recognised in the Managing Intellectual Property firm rankings for trade marks, with Tier 1 rankings and high recommendations in several key jurisdictions. Each year, …

Read article

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The Strawberry Patent Battle: Seeds, Speculation, and Jurisdiction

  This case, relating to infringement of a US plant patent, deals with the evidentiary burden required to show infringement of a plant patent in the US, as well as …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article

HGF ranked highly recommended in the WIPR Trade Mark Rankings 2025

HGF has been recognised as a leading firm in the recently published World IP Review (WIPR) Trade Mark Rankings 2025. This achievement highlights our continued commitment to excellence in trade …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our femtech specialists.